Cafeine to prevent Alzheimer disease? CAFCA clinical trial at the Lille University Hospital

Cafeine to prevent Alzheimer disease?

The Dr Thibaud Lebouvier, neurologist at the Memory Center of the  Lille University Hospital has received a grant to conduct the CAFCA clinical trial. This clinical trial aims to measure the capacity of coffee (more precisely cafeine) to slow down/prevent the symptoms of Alzheimer disease.

This project is in collaboration with Dr David Blum of the “Alzheimer and Tauopathy” team of the JP AUbert Research center in Lille